Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant dose-dense paclitaxel plus carboplatin for locally advanced cervical cancer
2016-003294-18Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in Cervical Cancer (CC), cervical adenocarcinoma, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jun 2021; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)cervical adenocarcinoma
Beyond the preview
Go deeper on 2016-003294-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003294-18.